The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Selection of Antiepileptic Drug Polytherapy Based on Mechanisms of Action: The Evidence Reviewed
Open accessAbstract
Summary: Purpose: When monotherapy with antiepileptic drugs (AEDs) fails, combination therapy is tried in an attempt to improve effectiveness by improving efficacy, tolerability, or both. We reviewed the available studies (both animal and human) on AED polytherapy to determine whether AEDs can be selected for combination therapy based on their mechanisms of action, and if so, which combinations are associated with increased effectiveness. Because various designs and methods of analysis were used in these studies, it was also necessary to evaluate the appropriateness of these approaches. Methods: Published papers reporting on AED polytherapy in animals or humans were identified by Medline search and by checking references cited in these papers. Results: Thirty‐nine papers were identified reporting on two‐drug AED combinations. Several combinations were reported to offer improved effectiveness, but no uniform approach was used in either animal or human studies for the evaluation of pharmacodynamic drug interactions; efficacy was often the only end point. Conclusions: There is evidence that AED polytherapy based on mechanisms of action may enhance effectiveness. In particular, combining a sodium channel blocker with a drug enhancing GABAergic inhibition appears to be advantageous. Combining two GABA mimetic drugs or combining an AMPA antagonist with an NMDA antagonist may enhance efficacy, but tolerability is sometimes reduced. Combining two sodium channel blockers seems less promising. However, given the incomplete knowledge of the pathophysiology of seizures and indeed of the exact mechanisms of action of AEDs, an empirical but rational approach for evaluating AED combinations is of fundamental importance. This would involve appropriate testing of all possible combinations in animal models and subsequent evaluation of advantageous combinations in clinical trials. Testing procedures in animals should include the isobologram method, and the concept of drug load should be the basis of studies in patients with epilepsy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berenbaum, M. C. (1989) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00026-2 · Cited by 1,414
Phenobarbital Compared with Phenytoin for the Treatment of Neonatal Seizures
Painter, M. J., Scher, M. S., Stein, A. D., Armatti, S., Wang, Z., Gardiner, J. C., Paneth, N., Minnigh, B., & Alvin, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410704 · Cited by 616
Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action
Löscher, W. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00075-6 · Cited by 532
Basic mechanisms of generalized absence seizures
Snead, O. C. (1995) · Annals of Neurology · doi:10.1002/ana.410370204 · Cited by 411
Lamotrigine substitution study: evidence for synergism with sodium valproate?
Brodie, M. J., & Yuen, A. W. C. (1997) · Epilepsy Research · doi:10.1016/s0920-1211(96)01007-8 · Cited by 379
Topiramate: Preclinical Evaluation of a Structurally Novel Anticonvulsant
Shank, R. P., Gardocki, J. F., Vaught, J. L., Davis, C. B., Schupsky, J. J., Raffa, R. B., Dodgson, S. J., Nortey, S. O., & Maryanoff, B. E. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb02459.x · Cited by 345
New visions in the pharmacology of anticonvulsion
Löscher, W. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01514-8 · Cited by 269
Update on the Mechanism of Action of Antiepileptic Drugs
Meldrum, B. S. (1996) · Epilepsia · doi:10.1111/j.1528-1157.1996.tb06038.x · Cited by 247
Pisani, F., Oteri, G., Russo, M. F., Di Perri, R., Perucca, E., & Richens, A. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00832.x · Cited by 247
Animal models of intractable epilepsy
Löscher, W. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00035-x · Cited by 244
Cited by
The importance of drug interactions in epilepsy therapy
Patsalos, P. N., Fröscher, W., Pisani, F., & Van Rijn, C. M. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.13001.x · Cited by 455
Self-citationPatsalos, P. N., & Perucca, E. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00409-5 · Cited by 423
Self-citationThe Expert Consensus Guideline Series
Karceski, S., Morrell, M., & Carpenter, D. (2001) · Epilepsy & Behavior · doi:10.1006/ebeh.2001.0283 · Cited by 396
Pharmacodynamic interactions of antiepileptic drugs: From bench to clinical practice
Verrotti, A., Lattanzi, S., Brigo, F., & Zaccara, G. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2020.106939 · Cited by 82
Zadrożniak, A., Wojda, E., Wlaź, A., & J. Łuszczki, J. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70128-8 · Cited by 22
Metadata
- Authors
- Deckers, C. L. P., Czuczwar, S. J., Hekster, Y. A., Kewser, A., Kubova, H., Meinardi, H., Patsalos, P. N., Renier, W. O., & Van Rijn, C. M.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2000-11
- Volume
- 41
- Issue
- 11
- Pages
- 1364-1374
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W2117821503
- Cited by
- 331
- References
- 46
- FWCI
- 12.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Selection of Antiepileptic Drug Polytherapy Based on Mechanisms of Action: The Evidence Reviewed. https://app.cochat.ai/papers/10.1111/j.1528-1157.2000.tb00111.x
- The paper
- Deckers, C. L. P., Czuczwar, S. J., Hekster, Y. A., Kewser, A., Kubova, H., Meinardi, H., Patsalos, P. N., Renier, W. O., & Van Rijn, C. M. (2000). Selection of Antiepileptic Drug Polytherapy Based on Mechanisms of Action: The Evidence Reviewed. Epilepsia. https://doi.org/10.1111/j.1528-1157.2000.tb00111.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.